691.00
-0.58%
Close of 9 Nov 2026, in PLN
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Neuca
Its shares trade on GPW under the ticker NEU.WA. It has been listed since 30 September 2004. In the fiscal year to 31 December 2025, it reported revenue of PLN 13.64bn and net income of PLN 155.6m. At that date it held total assets of PLN 6.33bn and shareholders' equity of PLN 1.06bn.
NEUCA SA engages in the wholesale of pharmaceutical products. The company is headquartered in Torun, Woj. Kujawsko - Pomorskie. The company went IPO on 2004-09-30. The firm is mainly involved in the distribution of drugs to pharmacies. The company also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 30 Sept 2004
- Employees
- 4,724
- Website
- neuca.pl ↗
Leadership
Pay as last reported
- Mr. Kazimierz HerbaChairman of the Supervisory Board, since 1994PLN 374,000
- Mr. Piotr SucharskiPresident of the Management Board, General DirectorPLN 2.9m
- Mr. Piotr BorowskiDeputy Chairman of the Supervisory BoardPLN 303,000
- Ms. Julita CzyzewskaVice President of the Management Board - Patient AreaPLN 1.4m
- Mr. Roman DudzikVice President of the Management Board - Area of Technology and DataPLN 1.3m
- Mr. Grzegorz DzikVice President of the Management Board - Business Support AreaPLN 2.2m
- Mr. Krzysztof MiszewskiVice President of the Management Board - Supply Chain DivisionPLN 1.8m
- Mr. Daniel WojtkiewiczVice President of the Management Board - Sales DivisionPLN 1.4m
- Ms. Wieslawa HerbaMember of the Supervisory Board, since 1994PLN 107,000
- Ms. Iwona SierzputowskaMember of the Supervisory BoardPLN 152,000
- Ms. Bozena SliwaMember of the Supervisory BoardPLN 48,000
- Dr. Tadeusz WesolowskiMember of the Supervisory BoardPLN 48,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 66
- Environment
- 72
- Social
- 99
- Governance
- 28
- Direct emissions (scope 1)
- 5,877.9 t
- Energy emissions (scope 2)
- 15,129 t
- Value chain emissions (scope 3)
- 37,369 t
- Women in the workforce
- 68.38152%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Neuca SA employs 4,724 full-time employees in the Health Care sector.
- The company distributes pharmaceutical products to pharmacies across Poland.
- Neuca SA operates in multiple health market segments including IT solutions and telemedicine.
Weaknesses
- Neuca SA's business is primarily focused on the Polish market.
- The company's distribution model relies heavily on pharmacy partnerships.
- Neuca SA has limited presence in international health care markets.
Opportunities
- Expanding into European Union health care markets presents growth potential.
- Increasing demand for telemedicine services in Poland offers new revenue streams.
- Growth in e-commerce for health care products can be leveraged by Neuca SA.
Threats
- Regulatory changes in the Polish pharmaceutical distribution sector could impact operations.
- Competition from international pharmaceutical distributors may affect market share.
- Economic downturns in Poland could reduce consumer spending on health care products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.